Discovery of clinically relevant fusions in pediatric cancer
Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 · Peer-reviewed
What this source contributed
Records in this release that cite this source. A record can cite several sources.
Results
Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.
Claims
Statements this source supports, each with where in the source it was checked.
- Evidence summary: tumour RNA fusion detection workflows: Summary Four comparisons join the Seraseq reference and paediatric NCH cohort evidence; values cannot be pooled across studies. Tamura et al. 2026 ran 12 short-read callers on haematologic cancer cell lines; one, Genomon, comes from a co-author's group. On 61 driver fusions in conventional RNA-seq of 170 cell lines, Arriba detected all 61 (TPR 1), FusionCatcher 0.98, STAR-Fusion 0.93, InFusion 0.43 and STARChip 0.41. On 24 driver fusions in targeted RNA-seq of 26 cell lines, Arriba again reached 1 and STAR-Fusion 0.92, InFusion 0.17 and STARChip 0. A driver fusion entered these truth sets only if at least four callers, including the one scored, found it and it had literature or RT-PCR support, so fusions that most callers miss are under-represented and these values may overstate sensitivity. Against a consensus of the other callers, the number of single-caller calls, a measure of review burden, ranged on conventional RNA-seq from 327 for TrinityFusion-D and 1,061 for STAR-Fusion (PPV 0.39) to 9,567 for Arriba (PPV 0.08), 22,445 for FusionCatcher and 695,295 for Pizzly. On nanopore long reads from 51 paediatric B-ALL samples (Lin et al. 2026), scored on the dominant fusion per sample, JAFFAL reached sensitivity 0.76, LongGF 0.70 and FusionSeeker 0.63, with precision 0.79 to 0.95; the authors' own FUSILLI reached 0.81. At about one eighth of the depth, sensitivity was 0.09 to 0.27. In an independent long-read benchmark (Dorney et al. 2026 preprint), no caller exceeded F1 0.35 on 400 simulated fusions at 100 Gb and 95% read identity: CTAT-LR-Fusion 0.35 (recall 0.28, precision 0.46), JAFFAL 0.29, Genion 0.20, FusionSeeker 0.14, GFSeeker 0.07 and LongGF 0.04. On all ONT PCR-cDNA reads of the MCF7 cell line, CTAT-LR-Fusion's calls matched 20 of 53 previously reported fusions, with 51 other calls; JAFFAL matched 19 with 38 other calls and FusionSeeker 11 with 359. The other calls mix real fusions missing from the literature list and false calls. On the Huh7 cell line, pooling six long-read callers per long-read platform and three short-read callers for Illumina, PacBio Kinnex recovered 20 of 34 previously reported fusions, ONT PCR-cDNA 17 and Illumina 15. Against karyotyping, FISH and RT-PCR in 101 adult and paediatric acute leukaemia patients (Kim et al. 2026), an Arriba workflow with manual review detected 40 of 48 conventionally detected fusions (sensitivity 83.3%) and called fusions in 21.4% of 56 conventionally negative results; these count against specificity, although the authors describe several as well-known recurrent fusions and confirmed one by RT-PCR and Sanger sequencing. These are cell lines, simulations and leukaemia samples: no linked comparison covers solid-tumour specimens, FFPE tissue or novel-fusion discovery, only Kim et al. score against orthogonal clinical assays, none reports interval estimates, and none establishes clinical performance. (amp-oncology-rna-20261007-source-pmc8642973: Seraseq and NCH results; rna-fusion-20261009-source-tamura2026-supplementary: Supplementary Tables 3 and 5; rna-fusion-20261009-source-tamura2026: Methods and Author contributions; rna-fusion-20261009-source-lin2026: Tables 3 and 6, Results; rna-fusion-longread-20261011-source-dorney2026: see claims.csv of its batch; rna-fusion-longread-20261011-source-dorney2026-repository: see claims.csv of its batch; rna-fusion-leukaemia-20261011-source-kim2025: see claims.csv of its batch)
- Relevance of EnFusion undiluted Seraseq duplicate benchmark to "Select a tumour RNA fusion-detection workflow": Assessed by EnFusion undiluted Seraseq duplicate benchmark (amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/)
- Relevance of NCH clinically relevant fusion ascertainment to "Select a tumour RNA fusion-detection workflow": Assessed by NCH clinically relevant fusion ascertainment (amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/)
Models, benchmarks and other records
Configurations (6)
Protocols (2)
Datasets (2)
Evaluations (6)
Use cases (1)
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
21 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Archive sha256 cf424d69172114c46db954db4f4f2caf6a638307ba8c1e71334e47463f16ca23 Source metadata | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact SHA-256 a5fd574d3b186fa29f835aff44491e1d1d0447ea2352f627c21f95ca666e9225 Source metadata | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact url https://www.ebi.ac.uk/europepmc/webservices/rest/PMC8642973/fullTextXML Source metadata | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Doi 10.1186/s12864-021-08094-z Source metadata | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Licence https://creativecommons.org/licenses/by/4.0/ Source metadata | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Media type application/xml Source metadata | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Original artifact sha256 a5fd574d3b186fa29f835aff44491e1d1d0447ea2352f627c21f95ca666e9225 Source metadata | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Publication status peer_reviewed Source metadata | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Retrieved at 2026-10-07T12:25:20.810843+00:00 Source metadata | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Review artifact format original_source_artifact Source metadata | Discovery of clinically relevant fusions in pediatric cancer No field-specific location recorded Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-adc15377fab2 · Record review: source checked
Primary source for the AMP oncology-RNA bounded intake. Automated review, not independent reproduction.
Technical metadata and extraction receipts
Stable ID: amp-oncology-rna-20261007-source-pmc8642973
- archive sha256
- cf424d69172114c46db954db4f4f2caf6a638307ba8c1e71334e47463f16ca23
- artifact sha256
- a5fd574d3b186fa29f835aff44491e1d1d0447ea2352f627c21f95ca666e9225
- artifact url
- https://www.ebi.ac.uk/europepmc/webservices/rest/PMC8642973/fullTextXML
- doi
- 10.1186/s12864-021-08094-z
- licence
- https://creativecommons.org/licenses/by/4.0/
- media type
- application/xml
- original artifact sha256
- a5fd574d3b186fa29f835aff44491e1d1d0447ea2352f627c21f95ca666e9225
- publication status
- peer_reviewed
- retrieved at
- 2026-10-07T12:25:20.810843+00:00
- review artifact
- data/omics/amp-coverage-20261007/oncology-rna/artifacts/PMC8642973.xml.gz
- review artifact format
- original_source_artifact
- review artifact matches original artifact sha256
- true
- url
- https://doi.org/10.1186/s12864-021-08094-z
- version
- Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00